Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells

This publication has 40 references indexed in Scilit:

• Cyclooxygenase-1 Deficiency in Bone Marrow Cells Increases Early Atherosclerosis in Apolipoprotein E– and Low-Density Lipoprotein Receptor–Null Mice
  Circulation, 2006
• Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT₁ receptor antagonist losartan
  British Journal of Pharmacology, 2001
• Thromboxane A ₂ and Vascular Smooth Muscle Cell Proliferation
  Hypertension, 1995
• Abundant expression of thromboxane synthase in rat macrophages
  FEBS Letters, 1994
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
  Published by Elsevier ,1992
• Mouse thromboxane A2 receptor: cDNA cloning, expression and Northern blot analysis
  Biochemical and Biophysical Research Communications, 1992
• Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
  New England Journal of Medicine, 1990
• Positive inotropic effect of the thromboxane analog U-46619 on guinea pig left atrium: mediation by specific receptors and association with increased phosphoinositide turnover
  Canadian Journal of Physiology and Pharmacology, 1989
• β-VLDL-induced alterations in growth potentiating activity produced by mononuclear phagocytes
  Atherosclerosis, 1988
• Transformation of arachidonic acid into thromboxane B2 by the homogenates of activated macrophages
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978